Condition: CD30-Positive Peripheral T-Cell Lymphoma · Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
The goal of this observational study is to evaluate how well brentuximab vedotin plus cyclophosphamide, doxorubicin, and prednisone (CHP) works and how safe it is when used as first-line treatment in adults with CD30-positive peripheral T-cell lymphoma in Spain during routine clinical care. The main questions this study aims to answer are: * How long do participants live without their lymphoma getting worse after starting treatment? * How well does this treatment reduce or eliminate the lymphoma? * How long do participants live after receiving this treatment? * What side effects do participants experience, including nerve problems and low white blood cell counts? Participants have already received brentuximab vedotin plus CHP as part of their usual medical care. Researchers will collect information from existing medical records to better understand treatment outcomes and safety in real-world clinical practice across multiple centers in Spain.
This description comes directly from the study's public registry record.
Eva Domingo Domenech, MD · 932697750 · edomingo@iconcologia.net
Always discuss trial participation with your own doctor first.
| Hospital Universitario A Coruña | A Coruña, A Coruña, Spain | Recruiting |
| Hospital Universitari Son Llàtzer | Palma de Mallorca, Balearic Islands, Spain | Recruiting |
| Hospital Universitari Son Espases | Palma de Mallorca, Balearic Islands, Spain | Recruiting |
| ICO Hospital Germans Trias i Pujol | Badalona, Barcelona, Spain | Recruiting |
| Hospital del Mar | Barcelona, Barcelona, Spain | Recruiting |
| Hospital Universitari Vall d'Hebron | Barcelona, Barcelona, Spain | Recruiting |
| Hospital Clínic de Barcelona | Barcelona, Barcelona, Spain | Recruiting |
| Hospital de la Santa Creu i Sant Pau | Barcelona, Barcelona, Spain | Recruiting |
| ICO Hospital Duran i Reynals | L'Hospitalet de Llobregat, Barcelona, Spain | Recruiting |
| Hospital Moisès Broggi | Sant Joan Despí, Barcelona, Spain | Recruiting |
| Hospital Universitario Marqués de Valdecilla | Santander, Cantabria, Spain | Recruiting |
| Hospital Universitario de Jerez | Jerez de la Frontera, Cádiz, Spain | Recruiting |
+ 25 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07624838